Potentially harmful staph bacteria can lurk deep inside the nose, a small new study finds. Researchers tested 12 healthy people and found that formerly overlooked sites deep within the nose may be reservoirs for Staphylococcus aureus, ...
U.S. allergists say a new long-term medication in under-the-tongue tablet form is promising and may even have the potential to cure hay fever. Officials at the American Academy of Allergy, Asthma & Immunology said allergy immunotherapy is ...
Linkage Biosciences announced the launch of the first commercially available real-time PCR KIR genotyping test at the 39th annual meeting of the American Society for Histocompatibility and Immunogenetics (ASHI). Killer cell ...
Tags: PCR KIR Test, Linkage Biosciences
Roche and Molecular Partners have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular' DARPin biologics conjugated to toxic agents ...
Tags: Roche, Molecular Partners
Those with HIV are living normal lifespans and their doctors should aim on preventive care for heart disease, diabetes and osteoporosis, U.S. researchers say. The Human Immunodeficiency Medicine Association of the Infectious Diseases ...
Tags: HIV, heart diease, HIV-infected, diabete, cancer
Those who play reed instruments -- clarinets and saxophones -- can get "saxophone lung" from the instrument if it is not properly cleaned, U.S. researchers say. In a case study presented at the American College of Allergy, Asthma and ...
Tags: reed instrument, saxophone lung, clean, organism, bacteria
Healthcare and medical research labs require the finest designs of lab devices to execute routine analytic applications with precision. Many experienced CCR (Central Specialist Registration) certified healthcare lab devices providers in the ...
Astellas Pharma US has launched ASTAGRAF XL (tacrolimus extended-release capsules), the first once-daily oral tacrolimus formulation, in the US market. The new product is indicated for the prophylaxis of organ rejection in patients ...
Pfizer is planning for internal classification of its commercial operations into three business segments, which will include developed and emerging markets, in an effort to deliver value to consumers and patients. The three business ...
Tags: Pfizer, Commercial Businesses
The US FDA has approved Janssen Biotech's Simponi ARIA (golimumab) for infusion to treat moderately to severely active rheumatoid arthritis (RA). Simponi ARIA is the only fully-human anti-tumor necrosis factor (TNF)-alpha infusible ...
Israeli Drug discovery company Compugen is developing a Predictive Structural Biology (PSB) infrastructure platform to identify the functional interaction sites of proteins, which are useful in the rational design of novel drugs. Intended ...
Second Genome has signed a microbiome drug discovery deal with Janssen Biotech to advance novel drug targets mediated by the bacterial ecosystem living within the human gut to treat ulcerative colitis. Under the collaboration, Janssen ...
Tags: Microbiome Drug, Medicine
Canada-based pharmaceutical company Nuvo Research has received US Patent relating to compositions and methods of using WF10 and new derivative formulations for the treatment of allergic asthma, allergic rhinitis and atopic dermatitis. ...
Tags: Nuvo Research, Drug Candidate
Merck, referred to as MSD outside the US and Canada, has announced the FDA acceptance of biologics license application (BLA) of investigational ragweed pollen (Ambrosia artemisiifolia) sublingual allergy immunotherapy tablet for review. ...
Tags: Merck Biologics, Medicine
Kerecis, a medical device company focused on the treatment of tissue damage with Omega3-based regenerative technologies, has announced that its recent clinical trial found no allergenic reactions to its fish-skin-composed MariGen Omega3 ...
Tags: Kerecis, Immunology Study